ARTICLE | Clinical News
SNP and haplotype testing of interleukin-1 regulatory update
January 29, 2001 8:00 AM UTC
ILGN received notice of allowance for a U.S. patent covering use of SNP and haplotyping of IL-1 genes for risk assessment testing and pharmacogenomic research. ...